RecruitingPhase 2NCT07517445
Bactericidal Activity and Safety of Nicotinamide in Combination With Bedaquiline, Pretomanid, and Linezolid in Drug-susceptible Pulmonary Tuberculosis
Studying Primary pulmonary tuberculosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Gates Medical Research Institute
- Principal Investigator
- Gates MRIGates Medical Research Institute
- Intervention
- Bedaquiline, pretomanid, linezolid(drug)
- Enrollment
- 165 target
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2026 – 2027
Study locations (4)
- Wits RHI - Shandukani Research, Johannesburg, Gauteng, South Africa
- The Aurum Institute Clinical Research Site - Pretoria, Pretoria, Gauteng, South Africa
- TASK Clinical Research Centre, Cape Town, Western Cape, South Africa
- Centre of Tuberculosis Research Innovation, Cape Town, Western Cape, South Africa
Collaborators
IQVIA RDS Inc.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07517445 on ClinicalTrials.govOther trials for Primary pulmonary tuberculosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07525427Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary TuberculosisGates Medical Research Institute
- RECRUITINGNANCT07484490Effects of the Active Cycle of Breathing Technique With and Without Balloon Blowing Therapy in TuberculosisRiphah International University
- RECRUITINGPHASE3NCT07209761A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary TuberculosisOtsuka Pharmaceutical Development & Commercialization, Inc.
- RECRUITINGPHASE2NCT07170800A Phase 2b Clinical Study of JDB0131 Benzenesulfonate TabletsWestVac Biopharma Co., Ltd.
- RECRUITINGPHASE2NCT06192160Trial of Novel Regimens for the Treatment of Pulmonary TuberculosisNational Institute of Allergy and Infectious Diseases (NIAID)
- RECRUITINGPHASE2NCT06748937A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With EthionamideTASK Applied Science
- ACTIVE NOT RECRUITINGNANCT07186478I-FALMIN Albumin Supplement for Patients With Pulmonary TuberculosisHasanuddin University
- ACTIVE NOT RECRUITINGPHASE3NCT06649721Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BDLL Chinese CohortHuashan Hospital